Tokyo - Delayed Quote
JPY
KYORIN Pharmaceutical Co., Ltd. (4569.T)
1,106.00
+1.00
(+0.09%)
At close: November 2 at 3:30:00 PM GMT+9
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in JPY.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Mr. Yutaka Ogihara
|
President, CEO & Chairman | -- | -- | 1967 |
|
Mr. Yasuji Kurose
|
CFO, CSO, Managing Executive Officer, Director of Corporate Planning & Executive Director | -- | -- | 1970 |
|
Junichi Ishiyama
|
Managing Executive Officer, CSO & Head of Drug Discovery Div. | -- | -- | -- |
|
Mr. Kenichi Nakamura
|
Managing Exec. Officer, CMO & President of KYORIN Pharma Grp Fac Co., Ltd. | -- | -- | -- |
|
Kiyoo Uehara
|
Managing Executive Officer, CHRO & General Affairs Manager | -- | -- | -- |
|
Takaaki Kaji
|
Sr Managing Executive Officer, CBDO & Head of Business Development Headquarters | -- | -- | -- |
|
Mr. Noriaki Tamura
|
Managing Executive Officer, CCO, Head of Pharmaceutical Sales Division & Director | -- | -- | 1966 |
KYORIN Pharmaceutical Co., Ltd.
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 1,982
Description
KYORIN Pharmaceutical Co., Ltd., through its subsidiaries, researches and develops, manufactures, and sells generic drugs in Japan and internationally. The company is also involved in drug discovery and licensing activities. It also offers infectious disease-related products; over-the-counter drug; and generic drugs. The company was formerly known as KYORIN Holdings, Inc. KYORIN Pharmaceutical Co., Ltd. was founded in 1923 and is headquartered in Tokyo, Japan.
Corporate Governance
KYORIN Pharmaceutical Co., Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of
Institutional Shareholder Services (ISS)
Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
November 9, 2026 at 6:30 AM UTC
KYORIN Pharmaceutical Co., Ltd. Earnings Date
March 30, 2027 at 12:00 AM UTC
Ex-Dividend Date
Recent Events
Recent Events Information Not Available
